SILEXION THERAPEUTICS CORP Other General and Administrative Expense
SILEXION THERAPEUTICS CORP (SLXN) reported Other General and Administrative Expense of $12.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-29.
Discontinued › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2024-08-29
- SILEXION THERAPEUTICS CORP other general and administrative expense for the quarter ending 2024-06-30 was $12.00K, a 0.00% change year-over-year.
- SILEXION THERAPEUTICS CORP other general and administrative expense for the quarter ending 2023-06-30 was $12.00K.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 6 month |
|---|---|---|
| 2024-06-30 | $12.00K 10-Q · filed 2024-08-29 | $24.00K 10-Q · filed 2024-08-29 |
| 2023-06-30 | $12.00K 10-Q · filed 2024-08-29 | $24.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |